BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12757770)

  • 1. Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.
    Ramacciotti E; Wolosker N; Puech-Leao P; Zeratti EA; Gusson PR; del Giglio A; Franco RF
    Thromb Res; 2003 Feb; 109(4):171-4. PubMed ID: 12757770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis.
    Nizankowska-Mogilnicka E; Adamek L; Grzanka P; Domagala TB; Sanak M; Krzanowski M; Szczeklik A
    Eur Respir J; 2003 Jan; 21(1):25-30. PubMed ID: 12570104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium].
    Dordević V; Rakićević L; Spasić M; Miković D; Kovać M; Radojković D
    Vojnosanit Pregl; 2005 Mar; 62(3):201-5. PubMed ID: 15790048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Factor V Leiden frequency is associated with venous thrombotic events among young Brazilian patients.
    de Paula Sabino A; Guimarães DA; Ribeiro DD; Paiva SG; Sant'Ana Dusse LM; das Graças Carvalho M; Fernandes AP
    J Thromb Thrombolysis; 2007 Dec; 24(3):261-6. PubMed ID: 17401546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.
    Wahba MA; Ismail MA; Saad AA; Habashy DM; Hafeez ZM; Boshnak NH
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.
    Salomon O; Steinberg DM; Zivelin A; Gitel S; Dardik R; Rosenberg N; Berliner S; Inbal A; Many A; Lubetsky A; Varon D; Martinowitz U; Seligsohn U
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):511-8. PubMed ID: 10073951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
    Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
    J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
    Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
    Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease.
    Couturaud F; Oger E; Abalain JH; Chenu E; Guias B; Floch HH; Mercier B; Mottier D; Leroyer C
    Respiration; 2000; 67(6):657-61. PubMed ID: 11124649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of factor V leiden, MTHFR C677T and MTHFR A1298C polymorphisms in patients with deep vein thrombosis in Central Iran.
    Ehsani M; Imani A; Moravveji A
    Mol Biol Rep; 2018 Aug; 45(4):621-624. PubMed ID: 29855758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
    Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
    J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis.
    Kupeli E; Verdi H; Simsek A; Atac FB; Eyuboglu FO
    Clin Appl Thromb Hemost; 2011; 17(6):E87-94. PubMed ID: 21078611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
    Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.
    Pourgheysari B; Boroujeni HR; Hasheminia AM; Drees F
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):471-6. PubMed ID: 23358226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
    Martinelli I; Battaglioli T; Razzari C; Mannucci PM
    J Thromb Haemost; 2007 Jan; 5(1):98-101. PubMed ID: 17067362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.